Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b t...

Post time 2024-4-19 13:43:25

journal：The Lancet Respiratory Medicine

Authors：Stefan Andreas; Marco Testa; Laurent Boyer; Guy Brusselle; Wim Janssens; Edward Kerwin; Alberto Papi; Bonavuth Pek; Luis Puente-Maestu; Dinesh Saralaya; Henrik Watz; Tom M.A. Wilkinson; Daniela Casula; Gennaro Di Maro; Maria Lattanzi; Luca Moraschini; Sonia Schoonbroodt; Annaelisa Tasciotti; Ashwani K. Arora; François Maltais; NTHi-Mcat-002 study group
Published date：2022-1-10

DOI：10.1016/S2213-2600(21)00502-6

PDF link：https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00502-6/abstract#

Article link：https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00502-6/abstract

Article Source：The Lancet。

Remark：

Post time 2024-4-19 13:43:26

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b t...

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b t... Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b t...